AI Discovers Antibiotics in Venom: A New Hope!

Quick Smiles:

• AI unveils hundreds of potential antibiotics from venom.
• Researchers synthesize 58 venom peptides for lab testing.
• 53 peptides effectively target drug-resistant bacteria.

In a fascinating blend of nature and technology, artificial intelligence has unlocked a treasure trove of potential antibiotics hidden within snake and spider venom.

This innovative approach has led to the identification of hundreds of promising drug candidates, offering a new ray of hope in the fight against antibiotic resistance.

The endeavor, led by researchers at a prominent university, utilized a deep-learning system known as APEX to comb through a vast database of venom peptides. These tiny proteins have evolved to protect animals by attacking the nervous system, blood cells, and organs of their prey or predators.

Within hours, the algorithm pinpointed 386 compounds that bore the molecular signatures of next-generation antibiotics.

“Venoms are evolutionary masterpieces, yet their antimicrobial potential has barely been explored,” remarked the senior study author, Professor César de la Fuente.

“APEX lets us scan an immense chemical space in just hours and identify peptides with exceptional potential to fight the world’s most stubborn pathogens.”

The research team synthesized 58 of these AI-selected venom peptides for further testing in the laboratory.

Their findings, published in a scientific journal, revealed that 53 of these peptides were effective in killing drug-resistant strains of bacteria, such as E. coli and Staphylococcus aureus, without harming human red blood cells.

“By pairing computational triage with traditional lab experimentation, we delivered one of the most comprehensive investigations of venom-derived antibiotics to date,” explained co-author Dr. Marcelo Torres.

The study also mapped out more than 2,000 new antibacterial motifs—specific sequences of amino acids within proteins or peptides that are responsible for their antibacterial properties.

The team is now focused on refining the most promising peptide candidates to develop new antibiotics through medicinal-chemistry enhancements.

This groundbreaking work highlights the potential of AI in revolutionizing medical research, providing a fresh arsenal in the ongoing battle against antibiotic-resistant pathogens.

Source